ArticleBMC microbiology2026
Establishment of a HicA toxin-based counterselection system for markerless genetic engineering in Veillonella atypica OK5.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Genetic manipulation in Veillonella atypica remains limited due to the scarcity of robust counterselection systems, hindering mechanistic studies of its role in oral biofilm ecology and host interactions. In this study, we adapted a highly efficient, HicA toxin–based counterselection system, originally developed for Fusobacterium nucleatum, for use in V. atypica OK5. We demonstrated that the inducible expression of a truncated Fusobacterium periodonticum HicA toxin, controlled by a theophylline-responsive riboswitch E, provides robust and reliable negative selection. The utility of this system was validated by generating a markerless deletion of the hemagglutinin gene hag1. The resulting Δhag1 mutant exhibited a complete loss of coaggregation with the early colonizer Streptococcus gordonii, confirming the essential role of Hag1 in interspecies adhesion. Furthermore, we constructed a hag1-luciferase transcriptional fusion reporter, which revealed that hag1 expression is growth-phase-dependent, peaking during early to mid-log phase. This work establishes the HicA system as a powerful genetic tool for Veillonella, enabling scarless gene deletions and promoter analysis, thereby facilitating future mechanistic studies of its role in oral biofilm development and microbial community dynamics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.